申请人:GlaxoSmithKline Intellectual Property Developement Limited
公开号:US20170197978A1
公开(公告)日:2017-07-13
The present invention relates to novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORγ.